Cancer attributable to HIV

Scientists from the International Agency for Research on Cancer (IARC) provide the first global assessment of the burden of cancer attributable to infection with HIV, in a new study published in The Lancet Global Health. The researchers also examined the burden and the principal attributable cancer types by world region, using data from the IARC GLOBOCAN 2022 database.

Cervical Cancer

The research team found vast regional disparities, with 70% of the 81 300 global cancer cases attributable to HIV infection occurring in Africa. Of these, more than 40% were cases of cervical cancer and 35% were cases of Kaposi sarcoma. Cancers attributable to HIV infection accounted for more than 5% of the total cancer burden in Africa as a whole and more than 10% of the total cancer burden in both Eastern Africa and Southern Africa.

Read more